John Mayfield
Chief Executive Officer JEO Biotech Advisors
Seminars
Tuesday 28th April 2026
Effectively & Efficiently Structuring Deals as Small Neuroscience Companies
5:30 pm
- Discussing the panel’s experience executing and performing due diligence across neuroscience deals – what are the learnings from having partnerships with pharma?
- Discussing how to get proof of concept earlier to secure additional investment or partnership
- Outlining opportunities for creative deal structures, and when and where they would be appropriate